Stocks In News (CTIC, SQNM, MITL)
Cell Therapeutics, Inc. (NASDAQ:CTIC) rose 2.60% to $0.377 after it it has submitted a formal appeal to the Office of New Drugs in the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research regarding the agency’s decision from earlier in 2010 on the pixantrone New Drug Application (NDA) to treat relapsed/refractory aggressive non-Hodgkin’s [...]
Biotech Stocks in Focus (CTIC, CELG, HGSI, SQNM)
Cell Therapeutics, Inc. (NASDAQ:CTIC) dropped 8.18% to $0.404 on about 7.45 million shares after it announced that the Pediatric Committee of the European Medicines Agency has adopted an opinion for the company’sPixuvri (pixantrone dimaleate) Pediatric Investigation Plan for the treatment of lymphoid malignancies and solid tumors in children between ages of 6 months and 18 [...]
Stock Movers on Unusual Volumes (SVU, CTIC, FHN, HT)
SUPERVALU INC. (NYSE:SVU) plunged 14.92% to $10.55 on about 18.17 million shares after it made its fresh 52-week low of $4. The company reported that it swung to a fiscal second quarter loss of $1.47 billion, or $6.94 per share, from a profit of $74 million, or 35 cents per share last year. On an [...]